학술논문
Assessment of rituximab-abbs, a biosimilar, and rituximab outcomes in patients with CLL or NHL: A real-world UK study
Document Type
Article
Author
Source
In Leukemia Research December 2021 111
Subject
Language
ISSN
0145-2126